{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:48:14Z","timestamp":1792532894860,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.canlet.2024.217282","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T03:18:49Z","timestamp":1728011929000},"page":"217282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling"],"prefix":"10.1016","volume":"605","author":[{"given":"Natisha R.","family":"Field","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie-Ann","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najah T.","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-4931","authenticated-orcid":false,"given":"Deborah J.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.217282_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.217282_bib3","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.217282_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055119","article-title":"The spectrum of SWI\/SNF mutations, ubiquitous in human cancers","volume":"8","author":"Shain","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217282_bib5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.tig.2020.07.011","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes: emerging mechanisms and therapeutic strategies","volume":"36","author":"Centore","year":"2020","journal-title":"Trends Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer \u2014 biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib7","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1002\/j.1460-2075.1996.tb00921.x","article-title":"Purification and biochemical heterogeneity of the mammalian SWI-SNF complex","volume":"15","author":"Wang","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2024.217282_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/370477a0","article-title":"Nucleosome disruption and enhancement of activator binding by a human SW1\/SNF complex","volume":"370","author":"Kwon","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.217282_bib9","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41467-022-29333-1","article-title":"BAF complex-mediated chromatin relaxation is required for establishment of X chromosome inactivation","volume":"13","author":"Keniry","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib10","first-page":"1271","article-title":"The BAF chromatin remodelling complex is an epigenetic regulator of lineage specification in the early mouse embryo","volume":"143","author":"Panamarova","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.canlet.2024.217282_bib11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41467-019-09582-3","article-title":"The maternal to zygotic transition regulates genome-wide heterochromatin establishment in the zebrafish embryo","volume":"10","author":"Laue","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2007.06.019","article-title":"An essential switch in subunit composition of a chromatin remodeling complex during neural development","volume":"55","author":"Lessard","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.canlet.2024.217282_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/ATVBAHA.109.187229","article-title":"The SWI\/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression","volume":"29","author":"Zhou","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.canlet.2024.217282_bib14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.stemcr.2019.03.012","article-title":"Comparative RNAi screens in isogenic human stem cells reveal SMARCA4 as a differential regulator","volume":"12","author":"G\u00fcne\u015f","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.canlet.2024.217282_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/biolre\/ioac209","article-title":"SWI\/SNF chromatin remodeling subunit Smarca4\/BRG1 is essential for female fertility","volume":"108","author":"Abedini","year":"2023","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.canlet.2024.217282_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1242\/dev.073478","article-title":"An essential role for a mammalian SWI\/SNF chromatin-remodeling complex during male meiosis","volume":"139","author":"Kim","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.canlet.2024.217282_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.18632\/oncotarget.2715","article-title":"SWI\/SNF complexes are required for full activation of the DNA-damage response","volume":"6","author":"Smith-Roe","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2024.217282_bib18","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1038\/sj.emboj.7601291","article-title":"Mammalian SWI\/SNF complexes facilitate DNA double\u2010strand break repair by promoting \u03b3\u2010H2AX induction","volume":"25","author":"Park","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2024.217282_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009981","article-title":"The SWI\/SNF chromatin remodeling assemblies BAF and PBAF differentially regulate cell cycle exit and cellular invasion in vivo","volume":"18","author":"Smith","year":"2022","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1101\/gad.342345.120","article-title":"BAF subunit switching regulates chromatin accessibility to control cell cycle exit in the developing mammalian cortex","volume":"35","author":"Braun","year":"2021","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2024.217282_bib21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1101\/gr.168930.113","article-title":"Tissue-specific SMARCA4 binding at active and repressed regulatory elements during embryogenesis","volume":"24","author":"Attanasio","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.canlet.2024.217282_bib22","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1038\/s41467-020-19402-8","article-title":"Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients","volume":"11","author":"Fernando","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/path.4926","article-title":"SMARCA4 inactivating mutations cause concomitant Coffin\u2013Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type","volume":"243","author":"Errichiello","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ajmg.c.31407","article-title":"Genotype-phenotype correlation of Coffin-Siris syndrome caused by mutations in SMARCB1, SMARCA4, SMARCE1, and ARID1A","volume":"166","author":"Kosho","year":"2014","journal-title":"Am. J. Med. Genet. Part C: Seminars in Medical Genetics"},{"key":"10.1016\/j.canlet.2024.217282_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbrc.2007.12.026","article-title":"Differentiation-specific expression of chromatin remodeling factor BRM","volume":"366","author":"Itoh","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/REP-08-0335","article-title":"Manipulation of SMARCA2 and SMARCA4 transcript levels in porcine embryos differentially alters development and expression of SMARCA1, SOX2, NANOG, and EIF1","volume":"137","author":"Magnani","year":"2009","journal-title":"Reproduction"},{"key":"10.1016\/j.canlet.2024.217282_bib27","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1093\/hmg\/ddt366","article-title":"A comprehensive molecular study on Coffin\u2013Siris and Nicolaides\u2013Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling","volume":"22","author":"Wieczorek","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib28","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/s41436-020-0898-y","article-title":"De novo SMARCA2 variants clustered outside the helicase domain cause a new recognizable syndrome with intellectual disability and blepharophimosis distinct from Nicolaides\u2013Baraitser syndrome","volume":"22","author":"Cappuccio","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.canlet.2024.217282_bib29","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.ajpath.2016.07.027","article-title":"B-lymphoblastic lymphomas evolving from follicular lymphomas Co-express surrogate light chains and mutated gamma heavy chains","volume":"186","author":"Slot","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038158","article-title":"New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing","volume":"7","author":"Dom\u00e9nech","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217282_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/his.13120","article-title":"BRM\/SMARCA2-negative clear cell renal cell carcinoma is associated with a high percentage of BRM somatic mutations, deletions and promoter methylation","volume":"70","author":"Xia","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2024.217282_bib32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.canlet.2014.11.038","article-title":"Frequent involvement of chromatin remodeler alterations in gastric field cancerization","volume":"357","author":"Takeshima","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217282_bib33","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/sj.onc.1210514","article-title":"The reversible epigenetic silencing of BRM: implications for clinical targeted therapy","volume":"26","author":"Glaros","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.217282_bib34","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.18632\/oncotarget.1945","article-title":"The silencing of the SWI\/SNF subunit and anticancer gene BRM in Rhabdoid tumors","volume":"5","author":"Kahali","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2024.217282_bib35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/onc.2012.613","article-title":"Identifying targets for the restoration and reactivation of BRM","volume":"33","author":"Kahali","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.217282_bib36","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1038\/s41467-022-34562-5","article-title":"Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers","volume":"13","author":"Cantley","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ygyno.2016.03.013","article-title":"The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type","volume":"141","author":"Witkowski","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib38","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/cancers15153794","article-title":"Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): patient characteristics, treatment, and outcome-A systematic review","volume":"15","author":"Wens","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217282_bib39","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type: a clinicopathological analysis of 150 cases","volume":"18","author":"Young","year":"1994","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5858\/arpa.2022-0297-OA","article-title":"A population-based study of patients with small cell carcinoma of the ovary, hypercalcemic type, encompassing a 30-year period","volume":"148","author":"Blatnik","year":"2023","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.canlet.2024.217282_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ygyno.2024.01.035","article-title":"A comprehensive population-based study of malignant ovarian tumors, including histologic and immunohistochemical review, in children and adolescents 0\u201319 years old in Sweden between 1970 and 2014","volume":"184","author":"Wessman","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib42","article-title":"Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","volume":"2","author":"Ramos","year":"2014","journal-title":"Rare Dis."},{"key":"10.1016\/j.canlet.2024.217282_bib43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/modpathol.2015.129","article-title":"Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type","volume":"29","author":"Jelinic","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Le Loarer","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib47","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ygyno.2017.09.031","article-title":"Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type","volume":"147","author":"Lin","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib49","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3390\/cancers16173068","article-title":"Aberrant SWI\/SNF complex members are predominant in rare ovarian malignancies\u2014therapeutic vulnerabilities in treatment-resistant subtypes","volume":"16","author":"Ma","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217282_bib50","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/cells9061496","article-title":"Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) beyond SMARCA4 mutations: a comprehensive genomic analysis","volume":"9","author":"Auguste","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2024.217282_bib51","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","article-title":"SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas","volume":"39","author":"Karanian-Philippe","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/his.12988","article-title":"Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics","volume":"69","author":"Clarke","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2024.217282_bib53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.4633","article-title":"Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type","volume":"238","author":"Karnezis","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib54","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41416-019-0687-z","article-title":"Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours","volume":"122","author":"Genestie","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217282_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-Deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cas.12065","article-title":"Lung cancer with loss of BRG1\/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features","volume":"104","author":"Matsubara","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2024.217282_bib57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/pin.12350","article-title":"Frequent loss of the expression of multiple subunits of the SWI\/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung","volume":"65","author":"Yoshimoto","year":"2015","journal-title":"Pathol. Int."},{"key":"10.1016\/j.canlet.2024.217282_bib58","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/PAS.0000000000001836","volume":"46","author":"Chang","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12957-022-02847-0","article-title":"Clinicopathological and prognostic significance of SWI\/SNF complex subunits in undifferentiated gastric carcinoma","volume":"20","author":"Zhang","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib61","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/his.13091","article-title":"Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology","volume":"70","author":"Ramalingam","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2024.217282_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non\u2013small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1265\/ehpm.21-00254","article-title":"SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution","volume":"27","author":"Sun","year":"2022","journal-title":"Environ. Health Prev. Med."},{"key":"10.1016\/j.canlet.2024.217282_bib64","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/his.14612","article-title":"Switch\/sucrose-non-fermentable (SWI\/SNF) complex (SMARCA4, SMARCA2, INI1\/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas","volume":"80","author":"Ahadi","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2024.217282_bib65","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217282_bib66","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000002296","article-title":"Additional considerations on aberrant BRG1 (SMARCA4) expression in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","author":"Cyrta","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib67","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/PAS.0000000000002295","article-title":"Reply to Letter by Cyrta et al, entitled \u201cAdditional considerations on aberrant BRG1 (SMARCA4) expression in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","volume":"48","author":"Mazibrada","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib68","article-title":"Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): a review and novel case with dual germline SMARCA4 and BRCA2 mutations","volume":"44","author":"Sanders","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.canlet.2024.217282_bib69","article-title":"Novel germline SMARCA4 mutation in small cell carcinoma of the ovary, hypercalcemic type","volume":"8","author":"Mehta","year":"2022","journal-title":"Curr. Probl. Cancer: Case Reports"},{"key":"10.1016\/j.canlet.2024.217282_bib70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/his.14110","article-title":"SWI\/SNF protein and claudin-4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum","volume":"77","author":"Chaudet","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2024.217282_bib71","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/modpathol.2017.11","article-title":"Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities","volume":"30","author":"Yoshida","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","article-title":"SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses","volume":"43","author":"Perret","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib73","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1066896919870866","article-title":"Cytopathological features of SMARCA4-deficient thoracic sarcoma: report of 2 cases and review of the literature","volume":"28","author":"Takeda","year":"2020","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib75","doi-asserted-by":"crossref","DOI":"10.1177\/23247096221074864","article-title":"SMARCA4-Deficient undifferentiated tumor of lung mass\u2014a rare tumor with the rarer occurrence of brain metastasis: a case report and review of the literature","volume":"10","author":"Yadav","year":"2022","journal-title":"Journal of Investigative Medicine High Impact Case Reports"},{"key":"10.1016\/j.canlet.2024.217282_bib76","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1066896919865944","article-title":"SMARCA4-Deficient thoracic sarcoma: a case report and review of literature","volume":"28","author":"Stewart","year":"2020","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6745","article-title":"A case of thoracic SMARCA4-Deficient undifferentiated tumor successfully treated with combination Ipilimumab\u2013Nivolumab","volume":"10","author":"Nakano","year":"2022","journal-title":"Clinical Case Reports"},{"key":"10.1016\/j.canlet.2024.217282_bib78","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-017-2148-5","article-title":"SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg\/CK7pos\/HepPar-1pos immunophenotype","volume":"471","author":"Agaimy","year":"2017","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2024.217282_bib79","first-page":"147","article-title":"Analysis of SMARCA4 and SMARCA2 loss in lung sarcomatoid carcinomas","volume":"39","author":"Urer","year":"2023","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.canlet.2024.217282_bib80","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10147-023-02403-0","article-title":"Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model","volume":"28","author":"Zhang","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib81","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/PAS.0000000000001599","article-title":"SMARCA4\/SMARCA2-deficient carcinoma of the esophagus and gastroesophageal junction","volume":"45","author":"Horton","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.humpath.2021.07.001","article-title":"Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors","volume":"116","author":"Kihara","year":"2021","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.5705","article-title":"SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type","volume":"255","author":"Andrianteranagna","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib84","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PAS.0000000000000787","article-title":"Rhabdoid and undifferentiated phenotype in renal cell carcinoma: analysis of 32 cases indicating a distinctive common pathway of dedifferentiation frequently associated with SWI\/SNF complex deficiency","volume":"41","author":"Agaimy","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib85","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.3390\/cancers13195030","article-title":"Methylation drivers and prognostic implications in sinonasal poorly differentiated carcinomas","volume":"13","author":"Libera","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217282_bib86","article-title":"SMARCA4-Deficient carcinoma of unknown primary presenting with fatal paraneoplastic hypercalcemia in a heart transplant recipient: first report in a male patient","volume":"2017","author":"Agaimy","year":"2017","journal-title":"Case Rep Pathol"},{"key":"10.1016\/j.canlet.2024.217282_bib87","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJMcpc1000272","article-title":"Case records of the Massachusetts General Hospital. Case 8-2010. A 22-year-old woman with hypercalcemia and a pelvic mass","volume":"362","author":"Young","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2024.217282_bib88","article-title":"Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: a retrospective observational cohort study","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.canlet.2024.217282_bib89","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/10935266211021213","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, in a 12-month-old girl","volume":"24","author":"Atwi","year":"2021","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib90","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10689-016-9957-6","article-title":"The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases","volume":"16","author":"Witkowski","year":"2017","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.canlet.2024.217282_bib91","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/jca.26978","article-title":"An in-depth look at small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): clinical implications from recent molecular findings","volume":"10","author":"Lu","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2024.217282_bib92","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59073","article-title":"Re-expression of SMARCA4\/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism","volume":"9","author":"Orlando","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2024.217282_bib93","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/his.13177","article-title":"Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm","volume":"70","author":"McCluggage","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2024.217282_bib94","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/curroncol29020037","article-title":"Case report of small cell carcinoma of the ovary, hypercalcemic type (ovarian rhabdoid tumor) with SMARCB1 mutation: a literature review of a rare and aggressive condition","volume":"29","author":"Sim\u00f5es","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.3746","article-title":"SMARCB1-mediated SWI\/SNF complex function is essential for enhancer regulation","volume":"49","author":"Wang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib96","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semcancer.2019.12.017","article-title":"Translational genomics of malignant rhabdoid tumours: current impact and future possibilities","volume":"61","author":"Finetti","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2024.217282_bib97","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.3390\/cancers14092185","article-title":"Infants and newborns with atypical teratoid rhabdoid tumors (ATRT) and extracranial malignant rhabdoid tumors (eMRT) in the EU-RHAB registry: a unique and challenging population","volume":"14","author":"Nemes","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217282_bib98","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41467-022-29152-4","article-title":"Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors","volume":"13","author":"Graf","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib99","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41467-021-21675-6","article-title":"Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours","volume":"12","author":"Custers","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib100","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1172\/JCI64400","article-title":"A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers","volume":"122","author":"Lee","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.217282_bib101","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.4362","article-title":"No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour","volume":"233","author":"Foulkes","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2350\/14-07-1531-MISC.1","article-title":"Rhabdoid tumor predisposition syndrome","volume":"18","author":"Sredni","year":"2015","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib103","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib104","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non\u2013small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib105","doi-asserted-by":"crossref","first-page":"24627","DOI":"10.18632\/oncotarget.5685","article-title":"Age-related somatic mutations in the cancer genome","volume":"6","author":"Milholland","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2024.217282_bib106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.217282_bib107","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12105-017-0783-4","article-title":"SMARCA4-deficient sinonasal carcinoma","volume":"11","author":"Agaimy","year":"2017","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.canlet.2024.217282_bib108","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217282_bib109","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2020.12.004","article-title":"Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines","volume":"160","author":"Karnezis","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41467-021-20940-y","article-title":"H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions","volume":"12","author":"Cai","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib111","doi-asserted-by":"crossref","first-page":"12249","DOI":"10.1073\/pnas.1703966114","article-title":"PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI\/SNF mutant tumors","volume":"114","author":"Januario","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.217282_bib112","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1535-7163.MCT-16-0678","article-title":"Selective killing of SMARCA2- and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2: in vitro and in vivo preclinical models","volume":"16","author":"Chan-Penebre","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2024.217282_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152867","article-title":"Inactivation of BRM\/SMARCA2 sensitizes clear cell renal cell carcinoma to histone deacetylase complex inhibitors","volume":"216","author":"Fang","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.canlet.2024.217282_bib114","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.gene.2017.05.047","article-title":"BRM promoter insertion polymorphisms increase the risk of cancer: a meta-analysis","volume":"626","author":"Ouyang","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2024.217282_bib115","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1038\/onc.2011.81","article-title":"Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk","volume":"30","author":"Liu","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.217282_bib116","doi-asserted-by":"crossref","first-page":"28093","DOI":"10.18632\/oncotarget.15890","article-title":"Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome","volume":"8","author":"Korpanty","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2024.217282_bib117","article-title":"Insertion\/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217282_bib118","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/carcin\/bgt008","article-title":"Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk","volume":"34","author":"Wang","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2024.217282_bib119","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.gene.2018.11.032","article-title":"Inactivation of SMARCA2 by promoter hypermethylation drives lung cancer development","volume":"687","author":"Wu","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2024.217282_bib120","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1158\/0008-5472.CAN-10-2345","article-title":"MicroRNAs miR-199a-5p and -3p target the brm subunit of SWI\/SNF to generate a double-negative feedback loop in a variety of human cancers","volume":"71","author":"Sakurai","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217282_bib121","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1158\/1535-7163.MCT-18-0348","article-title":"Histone deacetylase inhibitors synergize with catalytic inhibitors of EZH2 to exhibit antitumor activity in small cell carcinoma of the ovary, hypercalcemic type","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2024.217282_bib122","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/path.4912","article-title":"The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type","volume":"242","author":"Wang","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2024.217282_bib123","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41588-019-0363-5","article-title":"The ATPase module of mammalian SWI\/SNF family complexes mediates subcomplex identity and catalytic activity\u2013independent genomic targeting","volume":"51","author":"Pan","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.217282_bib124","doi-asserted-by":"crossref","first-page":"322","DOI":"10.18632\/oncoscience.323","article-title":"Loss of the SWI\/SNF ATPase subunits BRM and BRG1 drives lung cancer development","volume":"3","author":"Marquez-Vilendrer","year":"2016","journal-title":"Oncoscience"},{"key":"10.1016\/j.canlet.2024.217282_bib125","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1158\/2159-8290.CD-21-0248","article-title":"Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung","volume":"12","author":"Concepcion","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.217282_bib126","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/ijc.33937","article-title":"The association between bromodomain proteins and cancer stemness in different solid tumor types","volume":"150","author":"Czerwinska","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217282_bib127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.stem.2018.11.011","article-title":"Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance","volume":"24","author":"Gupta","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2024.217282_bib128","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1038\/s41467-021-25260-9","article-title":"SMARCA4\/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria","volume":"12","author":"Xue","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib129","doi-asserted-by":"crossref","first-page":"22876","DOI":"10.18632\/oncotarget.15283","article-title":"Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma","volume":"8","author":"Florea","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2024.217282_bib130","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type\u2013genetics, new treatment targets, and current management guidelines","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217282_bib131","doi-asserted-by":"crossref","first-page":"viii580","DOI":"10.1093\/annonc\/mdy299.011","article-title":"A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)","volume":"29","author":"Jones","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib132","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1038\/s41467-023-38594-3","article-title":"Alanine supplementation exploits glutamine dependency induced by SMARCA4\/2-loss","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib133","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib134","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41467-018-06958-9","article-title":"CDK4\/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217282_bib135","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cllc.2022.03.005","article-title":"Efficacy of immune checkpoint inhibitors in SMARCA4-deficient thoracic tumor","volume":"23","author":"Shinno","year":"2022","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.canlet.2024.217282_bib136","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejogrb.2024.04.001","article-title":"Immunotherapy combined with targeted therapy in advanced small cell carcinoma of the ovary of hypercalcemic type: a case of overall survival lasting for over 5 years","volume":"297","author":"Gao","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.canlet.2024.217282_bib137","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/PO.20.00063","article-title":"Combined CDK4\/6 and PD-1 inhibition in refractory SMARCA4-deficient small-cell carcinoma of the ovary, hypercalcemic type","volume":"4","author":"Lee","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.canlet.2024.217282_bib138","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1159\/000515416","article-title":"Ipilimumab and pembrolizumab mixed response in a 41-year-old patient with SMARCA4-deficient thoracic sarcoma: an interdisciplinary case study","volume":"14","author":"An\u017ei\u010d","year":"2021","journal-title":"Case Rep. Oncol."},{"key":"10.1016\/j.canlet.2024.217282_bib139","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jnci\/djx277","article-title":"Immune-Active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: rationale for immune checkpoint blockade","volume":"110","author":"Jelinic","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2024.217282_bib140","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/biomedicines10030650","article-title":"Immunotherapy for SMARCB1-deficient sarcomas: current evidence and future developments","volume":"10","author":"Ngo","year":"2022","journal-title":"Biomedicines"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524006773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524006773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T08:44:48Z","timestamp":1731487488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524006773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":140,"alternative-id":["S0304383524006773"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217282","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217282"}}